Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 8/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 8/20 | 0.41 |
| ▸ | TAS1R2 | Q8TE23 | 7/20 | 0.41 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.36 |
| ▸ | SPTLC2 | O15270 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL484780 | 0.93 | CYP2D6 (0.44) | TAS1R3TAS1R1TAS1R2SPTLC2CYP2D6 | |
| SCHEMBL484834 | 0.89 | TAS1R3 (0.36) | TAS1R3TAS1R1TAS1R2CYP2D6CYP3A4 | |
| SCHEMBL484652 | 0.88 | CYP2D6 (0.40) | TAS1R3TAS1R1TAS1R2CYP2D6CYP3A4 | |
| SCHEMBL484553 | 0.88 | CYP2D6 (0.49) | TAS1R3TAS1R1TAS1R2SPTLC2CYP2D6 | |
| SCHEMBL484497 | 0.86 | MRGPRX4 (0.38) | CYP3A4 | |
| SCHEMBL2817716 | 0.85 | TAS1R3 (0.43) | TAS1R3TAS1R1TAS1R2SPTLC2P2RX7 | |
| SCHEMBL484646 | 0.85 | TAS1R3 (0.43) | TAS1R3TAS1R1TAS1R2CYP2D6CYP3A4 | |
| SCHEMBL484832 | 0.85 | ACHE (0.42) | TAS1R3TAS1R1TAS1R2CYP2D6CYP3A4 | |
| SCHEMBL484426 | 0.83 | CYP2C9 (0.38) | TAS1R3TAS1R1TAS1R2CYP2D6CYP3A4 | |
| SCHEMBL484393 | 0.83 | TDP1 (0.38) | TAS1R3TAS1R1TAS1R2PDE10AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130231327-A1 | Substituted Spiro-Amide Compounds | GRUENENTHAL GMBH (DE) | 2013-09-05 | — | — | US | claimed |
| US-8455475-B2 | Substituted spiro-amide compounds | GRUENENTHAL GMBH (DE) | 2013-06-04 | — | — | US | claimed |
| US-20100249095-A1 | Substituted Spiro-amide Compounds | GRUENENTHAL GMBH (DE) | 2010-09-30 | — | — | US | claimed |
| US-20130231327-A1 | Substituted Spiro-Amide Compounds | GRUENENTHAL GMBH (DE) | 2013-09-05 | — | — | US | disclosed |
| US-8455475-B2 | Substituted spiro-amide compounds | GRUENENTHAL GMBH (DE) | 2013-06-04 | — | — | US | disclosed |
| EP-2411381-A1 | SUBSTITUTED SPIRO-AMIDE COMPOUNDS | Grünenthal GmbH (DE) | 2012-02-01 | — | — | EP | disclosed |
| US-20100249095-A1 | Substituted Spiro-amide Compounds | GRUENENTHAL GMBH (DE) | 2010-09-30 | — | — | US | disclosed |
| WO-2010108651-A1 | SUBSTITUTED SPIRO-AMIDE COMPOUNDS | Grünenthal GmbH (DE) | 2010-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130231327-A1 | Substituted Spiro-Amide Compounds | BDKRB1, BDKRB2, REN | TAS1R3 339/4885TAS1R1 107/4885TAS1R2 282/4885 |
| US-20100249095-A1 | Substituted Spiro-amide Compounds | BDKRB1, BDKRB2, REN | TAS1R3 339/4885TAS1R1 107/4885TAS1R2 282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.